The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments

被引:425
|
作者
Mahnke, K
Guo, M
Lee, S
Sepulveda, H
Swain, SL
Nussenzweig, M
Steinman, RM
机构
[1] Rockefeller Univ, Cellular Physiol & Immunol Lab, New York, NY 10021 USA
[2] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA
[3] Trudeau Inst Inc, Saranac Lake, NY 12983 USA
来源
JOURNAL OF CELL BIOLOGY | 2000年 / 151卷 / 03期
关键词
dendritic cell; antigen presentation; DEC-205; MHC class II; endocytosis;
D O I
10.1083/jcb.151.3.673
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Many receptors for endocytosis recycle into and out of cells through early endosomes. We now find in dendritic cells that the DEC-205 multilectin receptor targets late endosomes or lysosomes rich in major histocompatibility complex class II (MHC II) products, whereas the homologous macrophage mannose receptor (MMR), as expected, is found in more peripheral endosomes. To analyze this finding, the cytosolic tails of DEC-205 and MMR were fused to the external domain of the CD16 Fc gamma receptor and studied in stable L cell transfectants. The two cytosolic domains each mediated rapid uptake of human immunoglobulin (Ig)G followed by recycling of intact CD16 to the cell surface. However, the DEC-205 tail recycled the CD16 through MHC II-positive late endosomal/lysosomal vacuoles and also mediated a 100-fold increase in antigen presentation. The mechanism of late endosomal targeting, which occurred in the absence of human IgG, involved two functional regions: a membrane-proximal region with a coated pit sequence for uptake, and a distal region with an EDE triad for the unusual deeper targeting, Therefore, the DEC-205 cytosolic domain mediates a new pathway of receptor-mediated endocytosis that entails efficient recycling through late endosomes and a greatly enhanced efficiency of antigen presentation to CD4(+) T cells.
引用
收藏
页码:673 / 683
页数:11
相关论文
共 50 条
  • [41] Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading
    Robson, NC
    Beacock-Sharp, H
    Donachie, AM
    Mowat, AM
    [J]. IMMUNOLOGY, 2003, 109 (03) : 374 - 383
  • [42] Major histocompatibility complex class II inhibits Fas antigen-mediated gastric mucosal cell apoptosis through actin-dependent inhibition of receptor aggregation
    Stoicov, C
    Cai, X
    Li, HC
    Klucevsek, K
    Carlson, J
    Saffari, R
    Houghton, JM
    [J]. INFECTION AND IMMUNITY, 2005, 73 (10) : 6311 - 6321
  • [43] Murine cytomegalovirus inhibits interferonγ-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II associated genes
    Heise, MT
    Connick, M
    Virgin, HW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (07): : 1037 - 1046
  • [44] Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via toll-like receptor 2
    Barrionuevo, Paula
    Cassataro, Juliana
    Delpino, M. Victoria
    Zwerdling, Astrid
    Pasquevich, Karina A.
    Samartino, Clara Garcia
    Wallach, Jorge C.
    Fossati, Carlos A.
    Giambartolomei, Guillermo H.
    [J]. INFECTION AND IMMUNITY, 2008, 76 (01) : 250 - 262
  • [45] Pro- and anti-inflammatory cytokines control major histocompatibility complex (MHC) class II-dependent antigen presentation by dendritic dells through reciprocal regulation of intracellular protease activity
    Meraner, P
    Fiebiger, E
    Weber, E
    Fang, I
    Ploegh, H
    Stingl, G
    Maurer, D
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 530 - 530
  • [46] Slc11a1, formerly Nramp1, is expressed in dendritic cells and influences major histocompatibility complex class II expression and antigen-presenting cell function
    Stober, Carmel B.
    Brode, Sven
    White, Jacqueline K.
    Popoff, Jean-Francois
    Blackwell, Jenefer M.
    [J]. INFECTION AND IMMUNITY, 2007, 75 (10) : 5059 - 5067
  • [47] Modified Vaccinia Virus Ankara-Infected Dendritic Cells Present CD4+ T-Cell Epitopes by Endogenous Major Histocompatibility Complex Class II Presentation Pathways
    Thiele, Frank
    Tao, Sha
    Zhang, Yi
    Muschaweckh, Andreas
    Zollmann, Tina
    Protzer, Ulrike
    Abele, Rubert
    Drexler, Ingo
    [J]. JOURNAL OF VIROLOGY, 2015, 89 (05) : 2698 - 2709
  • [48] CHLOROQUINE ATTENUATES HEMORRHAGIC SHOCK-INDUCED SUPPRESSION OF KUPFFER CELL ANTIGEN PRESENTATION AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II ANTIGEN EXPRESSION THROUGH BLOCKADE OF TUMOR-NECROSIS-FACTOR AND PROSTAGLANDIN RELEASE
    ERTEL, W
    MORRISON, MH
    AYALA, A
    CHAUDRY, IH
    [J]. BLOOD, 1991, 78 (07) : 1781 - 1788
  • [49] Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3
    Lu, Yong-Chen
    Parker, Linda L.
    Lu, Tangying
    Zheng, Zhili
    Toomey, Mary Ann
    White, Donald E.
    Yao, Xin
    Li, Yong F.
    Robbins, Paul F.
    Feldman, Steven A.
    van der Bruggen, Pierre
    Klebanoff, Christopher A.
    Goff, Stephanie L.
    Sherry, Richard M.
    Kammula, Udai S.
    Yang, James C.
    Rosenberg, Steven A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (29) : 3322 - +
  • [50] SIGNALING VIA MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES AND ANTIGEN RECEPTORS ENHANCES THE B-CELL RESPONSE TO GP39/CD40 LIGAND
    BISHOP, GA
    WARREN, WD
    BERTON, MT
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (05) : 1230 - 1238